Table 2 Baseline characteristics of diabetes patients in HD and PD groups after matching

Demographic data

 Female (n)

11 (35.50%)

10 (34.50%)

0.94

 Age at dialysis initiation (years)

60.0 ± 11.7

54.6 ± 10.3

0.06

 Duration of follow up (months)

40.0 (31.0, 49.1)

54.0 (46.5, 61.6)

0.02

Kidney primary disease

 Diabetic nephropathy (n)

12 (38.70%)

16 (55.20%)

0.20

 Glomerulus nephritis (n)

8 (25.80%)

0 (0.00%)

<0.01

 Polycystic kidney (n)

1 (3.20%)

0 (0.00%)

0.33

 Obstructive nephropathy (n)

2 (6.50%)

4 (13.80%)

0.34

 Other or unknown (n)

8 (25.80%)

9 (31.00%)

0.65

Comorbidities

 Charlson Comorbidities Index (CCI)

6.4 ± 1.8

6.1 ± 1.3

0.54

 Cardiovascular disease (n)

13 (41.90%)

10 (34.50%)

0.55

 Congestive heart failure (n)

2 (6.50%)

3 (10.30%)

0.59

 Cerebrovascular disease (n)

9 (29.00%)

5 (17.20%)

0.28

 Chronic pulmonary disease (n)

6 (19.40%)

9 (31.0%)

0.30

Laboratory tests

 Serum Urea (mmol/L)

22.9 ± 6.6

25.7 ± 8.9

0.17

 Serum creatinine (umol/L)

814 (769, 859)

970 (839, 1101)

0.02

 Triglyceride (mmol/L)

2.4 (1.9, 2.9)

2.3 (1.7, 2.9)

0.80

 Cholesterol (mmol/L)

5.0 ± 1.1

5.6 ± 0.9

0.04

 Plasma albumin (g/L)

35.5 ± 4.7

34.7 ± 4.9

0.50

 Hemoglobin (g/L)

95.4 ± 18.3

97.5 ± 20.5

0.67